Back to top
more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$71.94 USD

71.94
987,515

-0.96 (-1.32%)

Updated Oct 1, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (170 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Medical Product Stock Earnings on Aug 6: CAH, HSIC & More

by Zacks Equity Research

The Medical product market gains momentum owing to the recent two-year suspension of the controversial 2.3% Medical Device tax.

    Can Dental Growth Drive Henry Schein's (HSIC) Q2 Earnings?

    by Zacks Equity Research

    Henry Schein (HSIC) is strongly placed to gain from the ongoing trend of digitalization in the global dental market.

      HSIC vs. ALGN: Which Stock Is the Better Value Option?

      by Zacks Equity Research

      HSIC vs. ALGN: Which Stock Is the Better Value Option?

        What's in Store for GNC Holdings (GNC) This Earnings Season?

        by Zacks Equity Research

        GNC Holdings' (GNC) revenues are likely to decline on a year-over-year basis, owing to weakness in U.S. & Canada segments in Q2.

          Will Edwards' (EW) Steady Overall Growth Drive Q2 Earnings?

          by Zacks Equity Research

          Edwards Lifesciences (EW) expected to gain from strength in all business segments and geographies in Q2.

            Can Overall Growth Drive Align Technology (ALGN) Q2 Earnings?

            by Zacks Equity Research

            Align Technology (ALGN) likely to gain from strength in Invisalign space as well as Scanner and Service business in Q2.

              Boston Scientific (BSX) Q2 Earnings: Is a Beat in Store?

              by Zacks Equity Research

              Boston Scientific (BSX) expects to consistently gain from impressive growth across all business lines and geographies.

                HSIC or MMSI: Which Is the Better Value Stock Right Now?

                by Zacks Equity Research

                HSIC vs. MMSI: Which Stock Is the Better Value Option?

                  BD Buys TVA Medical, To Provide Minimally Invasive Procedure

                  by Zacks Equity Research

                  The acquisition of TVA Medical will enable Becton, Dickinson (BDX) to treat patients with chronic kidney disease through minimally invasive procedures.

                    Henry Schein's JV With Internet Brands to Boost Dental Arm

                    by Zacks Equity Research

                    Henry Schein (HSIC) and Internet Brands' newly formed JV is likely to deliver integrated dental technology for improving practice management, marketing as well as patient communication.

                      Will Walgreens (WBA) Q3 Earnings Gain From Overall Strength?

                      by Zacks Equity Research

                      Walgreens Boots' (WBA) sales rise at the Retail Pharmacy USA segment on account of tie-ups along with strength in other businesses buoys optimism.

                        MedTech Overcomes Policy Hurdles, Long-Term Prospects Bright

                        by Zacks Equity Research

                        With the suspension of the controversial 2.3% medical device tax for another two years, the medical device industry is currently riding high on optimism.

                          Why is Henry Schein (HSIC) Down 1.1% Since its Last Earnings Report?

                          by Zacks Equity Research

                          Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                            Henry Schein's (HSIC) Q1 Earnings Beat, '18 View Intact

                            by Zacks Equity Research

                            We currently await the completion of Henry Schein's (HSIC) planned spin-off of global Animal Health business. This business contributes nearly 30% to the company's top line.

                              Henry Schein's (HSIC) Q1 Earnings & Revenues Top Estimates

                              by Zacks Equity Research

                              Henry Schein's (HSIC) four global segments gained market share during Q1 and delivered solid earnings growth on back of the strategy to grow the business organically and through acquisitions.

                                Can Overall Growth Drive Henry Schein's (HSIC) Q1 Earnings?

                                by Zacks Equity Research

                                Henry Schein (HSIC) likely to gain on strength across all business segments in Q1.

                                  Company News for Apr 24, 2018

                                  by Zacks Equity Research

                                  Companies in the news are: ALK,ASB,HSIC,HUM

                                    Factors Setting Stage for CVS Health's (CVS) Q1 Earnings

                                    by Zacks Equity Research

                                    CVS Health (CVS) expects robust 2018 PBM selling season and strong Pharmacy Services segment to drive earnings in Q1.

                                      Can Steady Overall Growth Drive Align's (ALGN) Q1 Earnings?

                                      by Zacks Equity Research

                                      Align Technology (ALGN) is likely to gain from strength in the Invisalign space as well as Scanner and Service business in Q1.

                                        Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings?

                                        by Zacks Equity Research

                                        Labcorp's (LH) multi-year LaunchPad project holds enough promise for growth. Good news is that the company already grossed savings worth $20 million from the same in 2017.

                                          Can S.E.T. Aid Zimmer (ZBH) Q1 Earnings Despite Supply Woes?

                                          by Zacks Equity Research

                                          Several FDA clearances within S.E.T since last November raise hope for Zimmer Biomet (ZBH) in Q1.

                                            What's in the Offing for Thermo Fisher (TMO) in Q1 Earnings?

                                            by Zacks Equity Research

                                            Thermo Fisher (TMO) benefits from its acquisition of FEI, consistently adding stimulus to its analytical instruments portfolio for over a year now.

                                              Can Solid Overall Growth Drive Illumina's (ILMN) Q1 Earnings?

                                              by Zacks Equity Research

                                              Illumina (ILMN) expected to gain from strong revenues at Product as well as Service and other segments in Q1.

                                                WATCHMAN to Aid Boston Scientific (BSX) Q1 Earnings Amid Woes

                                                by Zacks Equity Research

                                                The WATCHMAN platform is expected to experience a strong quarter on consistent global momentum as Boston Scientific's (BSX) multiple market development efforts continue to push for growth.

                                                  Will Edwards' (EW) Growth in All Lines Drive Q1 Earnings?

                                                  by Zacks Equity Research

                                                  Edwards Lifesciences (EW) is expected to gain from strength in all the business segments and solid performance across all geographies.